Back

Incident arrhythmias, heart failure and cardiovascular outcomes with SGLT-2 inhibitor use in diabetic patients: Insights from a global federated electronic medical record database

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: New on atrial fibrillation Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Ameenathul Mazaya Fawzy

Liverpool Heart and Chest Hospital, Liverpool (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
The 3S-AF scheme, rather than the 4S-AF scheme, predicts progression in patients with paroxysmal atrial fibrillation: data from RACE V study
Doctor V. Artola (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Evolving changes of outcomes in patients with newly diagnosed atrial fibrillation: a nationwide study.
Professor L. Fauchier (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation is associated with an increased risk of ventricular arrhythmias and sudden death in the general population
Doctor A. Fawzy (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project
Doctor A. Fawzy (Liverpool, GB)
Abstract Slides Video

Access the full session

Session thumbnail
New on atrial fibrillation

The Event

Event poster

EHRA 2022

3 April - 5 April 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources